P&G buys HDS Cosmetics Lab
This article was originally published in The Rose Sheet
Executive Summary
Procter & Gamble gains firm's Doctor's Dermatologic Formula (DDF) skin care line - designed for specific skin concerns such as anti-aging, acne, hyperpigmentation and sun protection - through an acquisition announced Jan. 22. Lauding DDF as a "leading dermatologist brand in the retail specialty channel [with] a strong following of loyal consumers," P&G says it will "infuse the line with a steady stream of innovation, add marketing expertise and leverage its global reach and go-to-market capability to drive future expansion." The move reflects P&G's sharpening focus on skin care as a key growth driver, company adds. P&G acquired the company from private equity firm North Castle Partners, which purchased a controlling interest in HDS in 2004 (1"The Rose Sheet" April 12, 2004, In Brief)...
You may also be interested in...
DDF acquisition
North Castle Partners private equity firm acquires a controlling interest in DDF skin care marketer HDS Cosmetics Lab, company announces April 8. DDF's positioning is consistent with North Castle's focus on healthy living and aging, and will give the firm a foothold in the rapidly growing cosmeceutical segment, Greenwich, Conn. firm says. HDS Cosmetics Lab CEO Joseph Contorno will remain with the firm in his current position. DDF generated sales of approximately $40 mil. in 2003, HDS Cosmetics says. New financing of the firm will also be funded by Easton Hunt capital partners and Easton Hunt New York, affiliates of the Easton Capital Group...
Abbott's ‘Bedrock Of Good Health’ Nutritionals Business Faces Mounting Infant Formula Litigation
Nutritional product business had 5.1% Q1 sales growth and is like Abbott’s other segments, “super well-aligned to the global demographics and trends in health care,” says CEO Ford. But as it defends complaints of damages from powder formulas made at facility found with unsafe levels of bacterial contaminants, Abbott’s also targeted in litigation alleging failure to warn about risk of infants born prematurely developing necrotizing enterocolitis if fed cow’s milk-based formula.
‘Core Pillars’ Of Safety And Innovation Take Center Stage In FDA Reports
The US FDA has issued a pair of reports focused on device safety and innovation. The reports describe recent steps the agency has taken to improve in the two areas, and what it plans to do next.